170 related articles for article (PubMed ID: 12907244)
1. The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine.
Marshall KM; Matsumoto SS; Holden JA; Concepción GP; Tasdemir D; Ireland CM; Barrows LR
Biochem Pharmacol; 2003 Aug; 66(3):447-58. PubMed ID: 12907244
[TBL] [Abstract][Full Text] [Related]
2. An improved high yield total synthesis and cytotoxicity study of the marine alkaloid neoamphimedine: an ATP-competitive inhibitor of topoisomerase IIα and potent anticancer agent.
Li L; Abraham AD; Zhou Q; Ali H; O'Brien JV; Hamill BD; Arcaroli JJ; Messersmith WA; LaBarbera DV
Mar Drugs; 2014 Sep; 12(9):4833-50. PubMed ID: 25244109
[TBL] [Abstract][Full Text] [Related]
3. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
4. AK37: the first pyridoacridine described capable of stabilizing the topoisomerase I cleavable complex.
Marshall KM; Holden JA; Koller A; Kashman Y; Copp BR; Barrows LR
Anticancer Drugs; 2004 Oct; 15(9):907-13. PubMed ID: 15457132
[TBL] [Abstract][Full Text] [Related]
5. Neoamphimedine circumvents metnase-enhanced DNA topoisomerase IIα activity through ATP-competitive inhibition.
Ponder J; Yoo BH; Abraham AD; Li Q; Ashley AK; Amerin CL; Zhou Q; Reid BG; Reigan P; Hromas R; Nickoloff JA; LaBarbera DV
Mar Drugs; 2011; 9(11):2397-2408. PubMed ID: 22163192
[TBL] [Abstract][Full Text] [Related]
6. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
[TBL] [Abstract][Full Text] [Related]
8. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.
Gowan SM; Harrison JR; Patterson L; Valenti M; Read MA; Neidle S; Kelland LR
Mol Pharmacol; 2002 May; 61(5):1154-62. PubMed ID: 11961134
[TBL] [Abstract][Full Text] [Related]
9. The total synthesis of neoamphimedine.
LaBarbera DV; Bugni TS; Ireland CM
J Org Chem; 2007 Oct; 72(22):8501-5. PubMed ID: 17900144
[TBL] [Abstract][Full Text] [Related]
10. The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes.
Oncogene; ; . PubMed ID: 16091739
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
